Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback